Get the Stockscreener App
72.62
0.92%
0.66
After Hours:
72.62
Grail Inc stock is traded at $72.62, with a volume of 413.76K.
It is up +0.92% in the last 24 hours and up +22.15% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$71.96
Open:
$70
24h Volume:
413.76K
Relative Volume:
0.62
Market Cap:
$3.12B
Revenue:
$156.12M
Net Income/Loss:
$-395.33M
P/E Ratio:
-6.999
EPS:
-10.3758
Net Cash Flow:
$-292.33M
1W Performance:
+0.86%
1M Performance:
+22.15%
6M Performance:
-24.90%
1Y Performance:
+102.17%
1-Day Range:
$69.69
$72.75
1-Week Range:
$69.45
$75.16
52-Week Range:
$29.95
$118.84
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
72.62 | 3.09B | 156.12M | -395.33M | -292.33M | -10.38 |
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Initiated | Mizuho | Neutral |
| Mar-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | TD Cowen | Hold |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Nov-12-25 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
View All
Grail Inc Stock (GRAL) Latest News
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intuit Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INTU - GlobeNewswire Inc.
GRAIL, INC. DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, - GlobeNewswire
GRAL INVESTOR DEADLINE: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - marketscreener.com
ROSEN, THE FIRST FILING FIRM, Encourages Zillow Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages BitGo Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
GRAL Shareholder Alert: August 4, 2026 Lead Plaintiff - GlobeNewswire
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GRAIL, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Priority Health partners with GRAIL for cancer test coverage By Investing.com - Investing.com South Africa
Priority Health partners with GRAIL for cancer test coverage - Investing.com
Why Is GRAL Stock Down Today? Analysts Lower Targets After UK Trial Setback But Call Selloff Overdone - Stocktwits
GRAIL, Inc. (GRAL) director receives 276 deferred stock units as fees - Stock Titan
GRAL DEADLINE: SueWallSt Reminds Grail, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire
GRAIL, INC. SECURITIES FRAUD NOTICE: Berger Montague Informs GRAIL, Inc. (GRAL) Investors of a Securities Fraud Lawsuit - marketscreener.com
GRAIL, INC. (GRAL) SHAREHOLDER ALERT Bernstein Liebhard LLP - GlobeNewswire
Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans - PR Newswire
GRAL STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Hagens Berman probes Grail over failed NHS-Galleri trial - scanx.trade
GRAL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Gr - The National Law Review
GRAL Investor Alert: HBSS Probes GRAIL, Inc. (GRAL) Following Securities Class Action Over Failed NHS-Galleri Trial - GlobeNewswire
GRAL Maintained by Mizuho -- Price Target Raised to $65.00 - GuruFocus
INVESTOR NOTICE: Robbins Geller Rudman and Dowd LLP - GlobeNewswire
GRAL Shareholder Alert: Grail, Inc. Securities Class Action LawsuitInvestors With Losses May Contact Levi & Korsinsky - PR Newswire
$GRAL Investor Loss Alert: GRAIL, Inc. Investors may have - GlobeNewswire
GRAL UPCOMING DEADLINE : The Gross Law Firm Alerts GRAIL, Inc. S - GuruFocus
INVESTOR NOTICE: GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman - PR Newswire
Grail, Inc. (GRAL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
GRAL UPCOMING DEADLINE : The Gross Law Firm Alerts GRAIL, Inc. Stockholders of Securities Class ActionContact the Firm - Barchart.com
GRAL Court News: GRAIL, Inc. Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses - PR Newswire
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GRAIL, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
GRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS - GlobeNewswire
Deadline Alert: Grail, Inc. (GRAL) Shareholders Who Lost - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Levi & Korsinsky Reminds Grail, Inc. Investors of the - GlobeNewswire
Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong. - Yahoo Finance
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit - Sahm
How Grail Inc Com (GRAL) Affects Rotational Strategy Timing - Stock Traders Daily
GRAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Grail (GRAL - The National Law Review
GRAL SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Grail - GlobeNewswire
GRAL INVESTOR ALERT: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead the Grail Class Action Lawsuit - TMX Newsfile
Robbins LLP Urges GRAL Stockholders to Contact the Firm for Information About the Class Action Against Grail, Inc. - marketscreener.com
GRAIL, Inc. (GRAL) Securities Class Action Filed Following - GlobeNewswire
INVESTOR REMINDER: Berger Montague Notifies GRAIL, Inc. (NASDAQ: GRAL) Investors of a Class Action Lawsuit and Deadline - lincolnjournal.com
GRAL Shareholder Alert: GRAIL, Inc. Securities Class Action - GlobeNewswire
INVESTOR NOTICE: RGRD Law Announces that GRAIL, Inc. (GRAL) - GlobeNewswire
GRAL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Grail, Inc. Securities LawsuitContact Levi & Korsinsky - Business Wire
GRAL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GRAIL, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR NOTICE: GRAIL, Inc. (GRAL) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- HBSS - Morgan County Citizen
Important Notice to Long-Term Shareholders of GRAIL, Inc. - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages GRAIL, Inc. Investors - GlobeNewswire
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.61%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):